EP2207775
4-Bensýlamínó-1-karboxýasýl-píperidínafleiður sem CETP hindrar sem eru nytsamlegir til meðhöndlunar á sjúkdómum eins og blóðfituaukningu eða slagæðaherðingu
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.11.2008EP published:
21.3.2012EP application number:
08848438.1
EP translation filed:
9.5.2012Grant published:
15.6.2012EPO information:
European Patent Register
Max expiry date:
2.11.2028Expiry date:
2.11.2020
Title:
4-BENZYLAMINO-1-CARBOXYACYL-PIPERIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLIPIDEMIA OR ARTERIOSCLEROSIS
Timeline
Today
3.11.2008EP application
21.3.2012EP Publication
9.5.2012Translation submitted
15.6.2012Registration published
2.11.2020Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
MOGI, MunetoAddress:
WalthamMA, US
Name:
YAMADA, KenAddress:
BostonMA, US
Name:
YASOSHIMA, KayoAddress:
CambridgeMA, US
Name:
KAWANAMI, ToshioAddress:
BostonMA, US
Name:
UMEMURA, IchiroAddress:
Ibaraki, JP
Name:
IWAKI, YukiAddress:
CambridgeMA, US
Name:
QIN, HongboAddress:
HanishinagunNagano, JP
Name:
IMASE, HidetomoAddress:
CambridgeMA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
985456 PDate:
5.11.2007Country:
US
Classification
Categories:
C07D 401/12, C07D 401/14, C07D 413/14, A61K 31/5377, A61P 3/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.10.2012
Expires: 2.11.2013
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 9.10.2013
Expires: 2.11.2014
Payer: Árnason Faktor
Number: 7
Paid: 7.10.2014
Expires: 2.11.2015
Payer: Árnason Faktor
Number: 8
Paid: 12.10.2015
Expires: 2.11.2016
Payer: Árnason Faktor
Number: 9
Paid: 26.10.2016
Expires: 2.11.2017
Payer: Árnason Faktor
Number: 10
Paid: 30.10.2017
Expires: 2.11.2018
Payer: Árnason Faktor
Number: 11
Paid: 23.10.2018
Expires: 2.11.2019
Payer: Árnason Faktor
Number: 12
Paid: 24.10.2019
Expires: 2.11.2020
Payer: Árnason Faktor